Emmanuel Lafont
Overview
Explore the profile of Emmanuel Lafont including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
158
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holub M, Lebeaux D, Grohs P, Joseph L, Pellerin O, Cheminet G, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Feb;
PMID: 39894862
Purpose: Although catheter-related infections are the leading cause of bloodstream infections in patients with sickle cell disease (SCD), data are scarce in adult patients. The objectives of the present study...
2.
Monpierre L, Angebault C, Hua C, Merio L, Ortonne N, Lafont E, et al.
Br J Dermatol
. 2025 Jan;
PMID: 39883852
No abstract available.
3.
Corbasson A, Fischer E, Vilfaillot A, Da Costa A, Charmettan M, Ferreira M, et al.
Int J Nurs Stud
. 2025 Jan;
163:104988.
PMID: 39787687
Background: Intravenous (IV) access is often required for the treatment of vaso-occlusive crises in patients with sickle cell disease, but can be particularly challenging due to recurrent venous damage. The...
4.
Cheminet G, Corbasson A, Charmettan M, Namaoui W, Khimoud D, Flamarion E, et al.
Br J Haematol
. 2024 May;
205(1):335-342.
PMID: 38802081
Few studies have used validated scales to assess the intensity and determinants of fatigue, a major symptom of sickle cell disease (SCD). We aimed to assess the level of basal...
5.
Lafont E, Sturny-Leclere A, Coelho C, Lanternier F, Alanio A
Methods Mol Biol
. 2024 May;
2775:157-169.
PMID: 38758317
Monocyte/macrophage cells play a central role in innate immunity against C. neoformans and C. gattii, species known to cause human disease. Cryptococcus is the only fungal genus known to possess...
6.
Peel J, Yang R, Le Voyer T, Gervais A, Rosain J, Bastard P, et al.
J Clin Invest
. 2024 Mar;
134(8).
PMID: 38470480
BACKGROUNDWeakly virulent environmental mycobacteria (EM) can cause severe disease in HLA-DRB1*15:02 or 16:02 adults harboring neutralizing anti-IFN-γ autoantibodies (nAIGAs). The overall prevalence of nAIGAs in the general population is unknown,...
7.
Melenotte C, Chavarot N, LHonneur A, Bodard S, Cheminant M, Flahault A, et al.
Open Forum Infect Dis
. 2024 Feb;
11(2):ofae012.
PMID: 38390457
Background: Immunocompromised patients now represent the population most at risk for severe coronavirus disease 2019. Persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral shedding was reported in these patients...
8.
Lafont E, Blez D, Bildan M, Veyer D, Pere H, Puech J, et al.
Clin Infect Dis
. 2023 Dec;
79(3):798-800.
PMID: 38159041
No abstract available.
9.
Thizy G, Flahault A, Scemla A, Roux O, Jarraud S, Lebeaux D, et al.
Chest
. 2023 Oct;
165(3):507-520.
PMID: 37839586
Background: Legionnaires disease (LD) is a rare, life-threatening opportunistic bacterial infection that poses a significant risk to patients with impaired cell-mediated immunity such as solid organ transplant recipients. However, the...
10.
Canoui E, Rossi G, Nguyen Y, Lafont E, Rossi B, Roux O, et al.
Mycoses
. 2023 Aug;
66(11):984-991.
PMID: 37534436
Background: Out of the context of haematological patients, Candida sp. is rarely retrieved from pyogenic liver abscesses (PLA). Objectives: Our objective was to assess the risk factors for occurrence, and...